KIMS Ltd to host institutional investor meet on September 10
- Krishna Institute of Medical Sciences Limited hosts investor meet on September 10, 2026
- Event begins at 2:30 pm at KIMS Mahadevpura facility
- Hosted by Emkay Global with group and one-on-one sessions
- Discussions limited to publicly available information only

*this image is generated using AI for illustrative purposes only.
Krishna Institute of Medical Sciences Limited will host an institutional investor meeting on September 10, 2026. The event aims to facilitate interaction between company officials and analysts.
The meeting is scheduled for Thursday, September 10, 2026, starting at 2:30 pm. It will be hosted by Emkay Global and held at the KIMS Mahadevpura facility.
Meeting Details
The company disclosed the schedule under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The format includes both group and one-on-one sessions conducted in person.
| Date / Time | Event | Type / Mode | Venue |
|---|---|---|---|
| September 10, 2026, 2:30 pm | Institutional Investor Meeting hosted by Emkay Global | Group Meeting / One on One – In Person | KIMS Mahadevpura |
Disclosure Notes
Discussions during the meeting will rely solely on publicly available information. The company confirmed that no unpublished price-sensitive information will be shared. The schedule remains subject to change due to exigencies on the part of participants or the company.
Nagajyanthi J. R, Company Secretary and Compliance Officer, signed the disclosure on September 7, 2026.
Historical Stock Returns for Krishna Institute of Medical Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.25% | +0.38% | -5.66% | +13.48% | +0.60% | 0.0% |
How might the strategic priorities discussed by KIMS management at this meeting influence their capital allocation for hospital expansions in 2027?
What specific operational metrics or growth targets is Emkay Global likely to probe regarding KIMS's post-pandemic recovery trajectory?
Could insights from this investor meeting signal any potential changes in dividend policy or share buyback plans for the upcoming fiscal year?


































